# Official Website: Curza

**Type:** source
**Status:** Useful
**Confidence:** Medium
**Source Type:** Official Website
**URL:** https://curza.com
**Publisher:** Curza
**Accessed:** 2026-06-19
**Updated:** 2026-06-19

## Summary

Curza's official website describes a small-molecule therapeutics company developing proprietary antibiotic classes focused on infectious diseases, with lead program CZ-02 targeting drug-resistant Gram-negative ESKAPE pathogens via an unexploited bacterial ribosome binding site.

## Useful Claims

- The site positions Curza as a small-molecule therapeutics company with several structurally distinct proprietary drug classes focused on infectious diseases.
- Lead program CZ-02 is described as a new class of broad-spectrum antibiotics focused on ESKAPE pathogens, especially drug-resistant Gram-negative bacteria.
- CZ-02 is said to be inspired by a natural product and to target an unexploited binding site on the bacterial ribosome.
- Additional program areas mentioned include ribosomal antibiotics for ESKAPE "superbugs" and antibiofilm antibiotics for infections such as tuberculosis, diabetic ulcers, Lyme disease, and cystic fibrosis-related infections.
- The site cites WHO framing of antibiotic resistance as a major global health threat.
- Company address listed: 650 Komas Drive, Suite 202, Salt Lake City, UT 84108.

## Reliability Notes

This is an official company source. It is useful for pipeline positioning, mechanism claims, and program structure, but preclinical potency, IND timing, clinical efficacy, and funding totals should be cross-checked with grant announcements, investor press releases, and peer-reviewed data before being treated as high-confidence evidence.

## Related Pages

- [Curza](curza.md)

## See Also

- [CARB-X partnership announcement](https://carb-x.org/carb-x-news/carb-x-teams-up-with-curza-to-develop-a-new-class-of-antibiotics-to-treat-drug-resistant-gram-negative-bacteria/) — third-party funder announcement
- [Novo Holdings REPAIR Fund investment](https://www.prnewswire.com/news-releases/curza-announces-5-25-million-investment-from-the-novo-holdings-repair-impact-fund-300890817.html) — impact-investor press release